Rubedo Reports Positive Phase I Results for RLS-1496 in Skin Conditions

Rubedo Life Sciences Reports Encouraging Phase I Results for RLS-1496 in Plaque Psoriasis, Atopic Dermatitis, and Aging Skin Rubedo Life Sciences, a clinical-stage biotechnology company focused on developing innovative therapies targeting cellular aging, has reported encouraging preliminary findings from its…










